Gowling WLG has advised Sosei Heptares on its global collaboration and license agreement with GlaxoSmithKline to advance the treatment of immune disorders of the digestive system….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
